T1	Concept 104 109	tests
T2	Concept 91 103	nucleic acid
T3	Concept 343 353	proportion
T4	Concept 568 575	results
T5	Concept 771 779	dynamics
T6	Concept 57 71	nasopharyngeal
T7	Concept 787 798	full system
T8	Action 576 582	showed
R1	subject Arg1:T8 Arg2:T4	
T9	Concept 555 567	experimental
R2	has-property Arg1:T4 Arg2:T9	
T10	Concept 612 624	U1 snRNA 294
T11	Action 625 634	decreased
T12	Concept 655 661	dosage
T13	Concept 641 643	4X
T14	Concept 645 647	9X
T15	Concept 652 654	6X
T16	Concept 693 699	HEK293
T17	Concept 709 713	SY5Y
T18	Concept 730 735	PC-12
T19	Concept 701 706	human
R3	in-place Arg1:T16 Arg2:T19	
T20	Concept 715 720	human
R4	in-place Arg1:T17 Arg2:T20	
T21	Concept 737 740	rat
R5	in-place Arg1:T18 Arg2:T21	
T22	Concept 742 752	cell lines
R6	is-a Arg1:T16 Arg2:T22	
R7	is-a Arg1:T17 Arg2:T22	
R8	is-a Arg1:T18 Arg2:T22	
R9	target Arg1:T8 Arg2:T11	
T23	Concept 592 608	expression level
R10	is-a Arg1:T13 Arg2:T12	
R11	is-a Arg1:T14 Arg2:T12	
R12	is-a Arg1:T15 Arg2:T12	
R13	causes Arg1:T12 Arg2:T11	
R14	in-place Arg1:T12 Arg2:T22	
R15	has-property Arg1:T7 Arg2:T5	
T24	Action 799 805	differ
R16	subject Arg1:T24 Arg2:T5	
T25	Concept 18 23	cases
T26	Action 53 56	use
T27	Action 44 49	tends
R17	subject Arg1:T27 Arg2:T25	
R18	target Arg1:T27 Arg2:T26	
T28	Concept 72 86	swab specimens
R19	in-place Arg1:T28 Arg2:T6	
R20	target Arg1:T26 Arg2:T28	
